Zobrazeno 1 - 10
of 11
pro vyhledávání: '"John R Brooklyn"'
Autor:
John R. Brooklyn, Dwight E. Matthews
Publikováno v:
Journal of addiction medicine. 16(6)
Treatment of opioid use disorder with methadone is highly effective. Methadone is dispensed from opioid treatment programs under regulated circumstances. However, diversion of take-home doses can occur and is difficult to detect. We wanted to test th
Autor:
Marne E. Stothart, Melanie Hanson, Vanessa Melamede Berman, Danielle Rylant, Mallory Stunell, John R Brooklyn
Publikováno v:
Journal of addiction medicine. 16(3)
Objectives Distance and travel costs to opioid treatment programs (OTPs), especially in rural communities, are barriers to treatment for opioid use disorder. Retention rates at 12 months in our OTP are 55% (range 53%-61%). We piloted a novel treatmen
Autor:
Valerie S. Harder, John R Brooklyn, Andrea C. Villanti, Insu Koh, Ethan B Rogers, Kathleen M. Fairfield, Timothy B Plante, Susan E. Varni
Publikováno v:
J Gen Intern Med
BACKGROUND: In response to the opioid epidemic, many states have enacted policies limiting opioid prescriptions. There is a paucity of evidence of the impact of opioid prescribing interventions in primary care populations, including whether unintende
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::168c267e08bcd1d719dbcd446ac00dcf
https://europepmc.org/articles/PMC8298594/
https://europepmc.org/articles/PMC8298594/
Autor:
Jacqueline Drouin, John R Brooklyn, Sanchit Maruti, Bradley J Tompkins, Stephen G DeVoe, Leigh Ann Holterman, Halle G. Sobel, Elly Riser
Publikováno v:
Substance abuse. 42(2)
Background Medications for opioid use disorder (MOUD) significantly reduce morbidity and mortality from opioid use disorder (OUD). To prescribe MOUD, physicians must obtain a DEA waiver through requirements outlined in the Drug Addiction Treatment Ac
Publikováno v:
Journal of addiction medicine. 14(6)
Treatment with medications for opioid use disorder such as buprenorphine improves patient morbidity and mortality as well as treatment adherence, an important component of patient care. Buprenorphine is combined with naloxone to reduce misuse; and, w
Vermont Hub-and-Spoke Model of Care for Opioid Use Disorder: Development, Implementation, and Impact
Autor:
Stacey C. Sigmon, John R Brooklyn
Publikováno v:
Journal of addiction medicine. 11(4)
Background Opioid use disorders (OUDs) are reaching epidemic proportions in the United States, and many geographic areas struggle with a persistent shortage in availability of opioid agonist treatment. Over the past 5 years, Vermont addiction medicin
Autor:
Robert P. Schwartz, Bryce Hruska, Brent A. Moore, Gary J. Badger, Sarah H. Heil, Andrew C. Meyer, John R Brooklyn, Gail L. Rose, Stacey C. Sigmon, Stephen T. Higgins, Taylor A. Ochalek
In 50 opioid users on a waiting list for maintenance treatment, those assigned to interim treatment with buprenorphine submitted a higher percentage of urine specimens that were negative for illicit opioids than those in the control group at 4 weeks
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cec98782c162c14ed8bb8c1a0f3c1fad
https://europepmc.org/articles/PMC5373028/
https://europepmc.org/articles/PMC5373028/
Autor:
Nels Kloster, Andrea Meier, Elizabeth C. Saunders, Clifton Frederick Lord, John R Brooklyn, Mark P. McGovern, Haiyi Xie, Benjamin R. Nordstrom, Gregory King, Chantal Lambert-Harris, William Roberts, Beth Tanzman, Bethany McLeman
OBJECTIVES Rapidly escalating rates of heroin and prescription opioid use have been widely observed in rural areas across the United States. Although US Food and Drug Administration-approved medications for opioid use disorders exist, they are not ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b156b3563283500b6559917d6c5270a2
https://europepmc.org/articles/PMC4865252/
https://europepmc.org/articles/PMC4865252/
Autor:
Robert P. Schwartz, Brent A. Moore, Gail L. Rose, John R Brooklyn, Stephen T. Higgins, Gary J. Badger, Sarah H. Heil, Andrew C. Meyer, Taylor A. Ochalek, Bryce Hruska, Stacey C. Sigmon
Despite the effectiveness of agonist maintenance for opioid dependence, individuals can remain on waitlists for months, during which they are at significant risk for morbidity and mortality. Interim dosing, consisting of daily medication without coun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc3a9f0b6d18750be459e3ed69397a38
https://europepmc.org/articles/PMC4558243/
https://europepmc.org/articles/PMC4558243/
Autor:
Stephen T. Higgins, Kathryn A. Saulsgiver, Sarah H. Heil, Stacey C. Sigmon, Kelly E. Dunn, Mollie E. Patrick, Gary J. Badger, John R Brooklyn
Publikováno v:
JAMA psychiatry. 70(12)
Although abuse of prescription opioids (POs) is a significant public health problem, few experimental studies have investigated the treatment needs of this growing population.To evaluate, following brief stabilization with a combination of buprenorph